SGLT2 inhibitor therapy and clinical outcomes in HIV-related cardiomyopathy
SGLT2i use was associated with significant reductions in all-cause mortality and hospitalizations in patients with HIV-CM.
Authors
- Hesham Sheashaa
- Isabel G. Scalia (ORCID: https://orcid.org/0000-0002-6459-9767)
- Juan Farina (ORCID: https://orcid.org/0000-0002-5824-8485)
- Chadi Ayoub
- Hoang Nhat Pham
- Reza Arsanjani
- Balaji Tamarappoo
- Kamal Awad
- Ramzi Ibrahim
- Cameron Holloway
Institutions
- University of Arizona (US)
- WinnMed (US)
- St Vincent's Hospital Sydney (AU)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- American Heart Journal Plus Cardiology Research and Practice
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1016/j.ahjo.2026.100722
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00